Switzerland· 61330001
Vimovo, Filmtabletten
A naproxen and esomeprazole product, registered in Switzerland by Grünenthal Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 12 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Naproxen and esomeprazole is registered in 12 of 19 countries.
Countries holding a registration under ATC M01AE52 (naproxen and esomeprazole), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Naproxen and esomeprazole · ATC M01AE52
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naproxen and esomeprazole costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- Switzerland: $0.91 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Naproxen and esomeprazole · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.91
The record
At a glance
- Manufacturer
- Grünenthal Pharma AG
- Country
- Switzerland (CH)
- ATC code
- M01AE52
- ATC class
- Naproxen and esomeprazole
- Defined daily dose
- 0.5 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for naproxen and esomeprazole.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naproxen and esomeprazole · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under M01AE52
Naproxen and esomeprazole, as other registers publish it.
- PolandEmoxenBausch Health Ireland Ltd.
- CzechiaEMOXEN PLUSBausch Health Ireland Limited, Dublin
- CzechiaEMOXEN PLUSBausch Health Ireland Limited, Dublin
- FinlandEmoxenduoBausch Health Ireland Limited
- DenmarkEmoxenduoBausch Health Ireland Limited
- PolandESONALGENSandoz Polska Sp. z o.o.
- CanadaMYLAN-NAPROXEN/ESOMEPRAZOLE MRMYLAN PHARMACEUTICALS ULC
- CanadaMYLAN-NAPROXEN/ESOMEPRAZOLE MRMYLAN PHARMACEUTICALS ULC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afc118e6-fa98-4c6f-a2bb-c980f97525d8 GET /v1/drugs/afc118e6-fa98-4c6f-a2bb-c980f97525d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about naproxen and esomeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.